COMBATdb
COMBATdb provides a curated multi-omics database to enable integrative analysis of human blood responses to SARS-CoV-2 infection.
Key Features:
- Multi-Omics Integration: Integrates whole blood transcriptomics, plasma proteomics, epigenomics, single-cell multi-omics, immune repertoire sequencing, flow cytometry, and mass cytometry.
- Diverse Sample Cohorts: Includes cohorts of hospitalized COVID-19 patients across severities, community cases, healthy controls, and patients with all-cause sepsis and influenza.
- Processed Data and Annotations: Provides processed datasets with sample-level metadata and categorizations by cell type and gene/protein to support cross-modal analyses.
- Comparative Analysis: Enables comparative studies between COVID-19 and other infectious diseases to identify shared and disease-specific immunological features.
Scientific Applications:
- Pathogenesis of COVID-19: Supports dissection of immune responses to characterize mechanisms of SARS-CoV-2 pathogenesis.
- Precision Medicine: Facilitates analysis of individual variation in immune profiles to inform patient-specific therapeutic strategies.
- Comparative Immunology: Allows identification of unique and common immune pathways across COVID-19, sepsis, and influenza cohorts.
Methodology:
Processed multi-omics profiles are organized into a structured framework for multi-modal data exploration.
Topics
Collections
Details
- License:
- Not licensed
- Tool Type:
- web application
- Operating Systems:
- Mac, Linux, Windows
- Programming Languages:
- R
- Added:
- 1/27/2023
- Last Updated:
- 11/24/2024
Operations
Publications
Wang D, Kumar V, Burnham KL, Mentzer AJ, Marsden BD, Knight JC. COMBATdb: a database for the COVID-19 Multi-Omics Blood ATlas. Nucleic Acids Research. 2022;51(D1):D896-D905. doi:10.1093/nar/gkac1019. PMID:36353986. PMCID:PMC9825482.
DOI: 10.1093/nar/gkac1019
PMID: 36353986
PMCID: PMC9825482
Funding: - Wellcome Trust: 090532/Z/09/Z, 108413/A/15/D, 203141/Z/16/Z, 206194
- Wellcome Trust Investigator Award: 204969/Z/16/Z
- Medical Research Council: MR/V002503/1
- Innovation Fund for Medical Science: 2018-I2M-2-002